Effect of Phosphamidon and Obidoxime on the QT-RR Relationship of Isolated Rat Heart
Autor: | Haim Ben-Ami, Yeouda Edoute, U. Taitelman, Gal Hayam, Shlomo Ben-Haim |
---|---|
Rok vydání: | 1992 |
Předmět: |
Male
Obidoxime medicine.medical_specialty Obidoxime Chloride Health Toxicology and Mutagenesis medicine.medical_treatment In Vitro Techniques Toxicology QT interval Rats Sprague-Dawley Electrocardiography chemistry.chemical_compound Internal medicine medicine Animals Ventricular Function Antidote Pharmacology Cardiac cycle Phosphamidon Organophosphate Heart Rats Electrophysiology Perfusion Endocrinology chemistry Toxicity cardiovascular system Drug Therapy Combination medicine.drug |
Zdroj: | Pharmacology & Toxicology. 70:402-406 |
ISSN: | 1600-0773 0901-9928 |
Popis: | We studied the effects of phosphamidon (an organophosphate compound), obidoxime (a cholinesterase reactivator), and their combination, phosphamidon/obidoxime (PD/OB) on cardiac cycle length (RR), QT interval, and on QT-RR relationship of isolated rat heart. Cardiac cycle length did not change significantly following perfusion with phosphamidon or obidoxime alone; however, following perfusion with PD/OB, RR significantly increased at high concentrations (10(-3) M) of both drugs. The QT interval lengthened by 5% following perfusion with phosphamidon, did not change following perfusion with obidoxime, and increased by 10% following perfusion with PD/OB. The QT-RR relationship without drugs was positive and linear. Following perfusion with phosphamidon alone, the slope of the relationship decreased significantly, while perfusion with obidoxime alone did not change the QT-RR relationship. Perfusion with PD/OB at low concentrations decreased the slope of the relationship; however, at the highest concentration (10(-3) M) the QT-RR relationship was inverted and became negative. Ventricular arrhythmias as premature ventricular beats, or bigeminies, were noted with increasing frequency following perfusion with increasing doses of phosphamidon. Perfusion with obidoxime did not cause arrhythmias, whereas perfusion with PD/OB caused premature ventricular beats, bigeminies, and ventricular tachycardias at high doses. We suggest that obidoxime modulates the direct effects of phosphamidon on the cardiac repolarization process. PD/OB at high concentrations invert the normal depolarization-repolarization coupling and may therefore potentiate arrhythmias. |
Databáze: | OpenAIRE |
Externí odkaz: |